Warning letter
AMS Health Sciences: warning letter of Jul 25, 2014
FDA warning letter 422686 · Dallas District Office
Key facts
| Reference number | 422686 |
|---|---|
| Company | AMS Health Sciences |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Jul 25, 2014 |
| Posted date | Sep 30, 2014 |
| Issuing office | Dallas District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.65, 111.103, 111.465, 111.553, 101.4(g), 101.9(b), 101.9(b)(8), 111.70(e), 111.83(a), 111.105(a), 111.560(b), 101.36(d) and 5 more |
| Inspection city | Oklahoma City |
| Inspection ZIP | 73105 |
| Inspection start date | Nov 19, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: